-
Company Search
-
Search Results
-
Purchase Options
Selected Company
BIND Biosciences, Inc.Cambridge, MA |
|
|
Develops therapeutic targeted nanoparticles that treat patients by concentrating drugs in the target tissue while minimizing systemic exposure. The Company's technology platform gives them the ability to produce nanoparticles optimized for their specific therapeutic application. BIND is generating a product pipeline in multiple therapeutic areas, initally focusing the development efforts cancer and cardiovascular diseases. |
Geographic Region: New England Industry Sector: Biotechnology Capital Invested: 18.63mm Number of Financings: 3 Most Recent Financing: November 14, 2007 |
Purchase Options
|
1 Month KIT Access - $325.00 Access complete data for this and all other companies in KIT for one month (no commitment required). If you need more information about KIT, please see both the "Using KIT" section and the Sample Company Report. If you need more than one license to KIT or an extended license, please call 646-290-9254. |
12 Month KIT Access - Best Value! Access complete data for this and all other companies in KIT for 12 months. If you need more than one license to KIT or an extended license, please call 646-290-9254. |
|
|
|
|
What Is KIT?
K.I.T. reveals valuations, investment data and the terms, investors, and analytics of each venture-backed deal. Search by: industry sector, geographic location, or financing round - and K.I.T. will match it to our internal dataset of deal terms. Download the charter certificate in PDF for each company. Data, Analytics, Deal Terms. We Make Private Equity Public.
How Does KIT Work?
K.I.T. reveals investment data and the terms, investors, and analytics of each deal. Search by: industry sector, geographic location, or financing round - and K.I.T. will match it to our internal dataset of deal terms. Download the charter certificate in PDF for each company. Data, Analytics, Deal Terms. We Make Private Equity Public.
Business Intellegence
We can provide business intelligence to private equity and venture investors, hedge funds and other debt and equity investors by data mining our proprietary database. Under normal circumstances, these reports are delivered in a digital report format within 36 hours of the request. Call our analyst team at 646-290-9254 to see how we can assist you with your next business transaction.
Questions? Call 646-290-9254
Register Now
Register a FREE account! When you register a free account, you gain access to valuable tools and services that you can use to answer the all-important question, "What's My Company Worth?". In addition, you are assured of receiving the latest updates to the Private Equity Data Center.
The PEDC Buzz 
» Deal Terms in the Biotechnology Industry (Q3 2008)
» Private Company Valuations: Cleantech (Q3 2008)